Skip to main content
. Author manuscript; available in PMC: 2023 Jul 2.
Published in final edited form as: Biochem Pharmacol. 2021 Jul 30;192:114714. doi: 10.1016/j.bcp.2021.114714

Figure 2:

Figure 2:

The advantages vs. limitations of EVs as carriers of natural molecules. Despite the outweighing advantages (left plate), the therapeutic use of EVs comes with limitations that need to be addressed using novel strategies (lower left plate). EV, Extracellular vesicle; RBC, Red blood cell